Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics

scientific article

Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.36.6.1471-1479.1998
P932PMC publication ID104860
P698PubMed publication ID9620364

P50authorRobert W CoombsQ98719827
Lynne MofensonQ43882680
P2093author name stringW Meyer
M Fowler
B Jackson
B Weiser
A Kovacs
M Cronin
K McIntosh
J Kornegay
T Quinn
N Michael
D Chernoff
J Moye
S Herman
J Bremer
S Fiscus
M Robb
J Lew
P Reichelderfer
R Dickover
S Cassol
M Vahey
R Carrol
T Yeghiazarian
P2860cites workGenital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiencyQ24606530
Natural History of HIV-1 Cell-Free ViremiaQ50595390
Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 × 106/lQ56791561
The effect of maternal viral load on the risk of perinatal transmission of HIV-1Q57231820
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral loadQ61111961
Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technologyQ71726486
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversionQ72624142
Rapid and simple method for purification of nucleic acidsQ29615124
Prognosis in HIV-1 infection predicted by the quantity of virus in plasmaQ29619980
Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmissionQ33647718
Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR.Q33661973
Absolute copy number and relative change in determinations of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparisonsQ34073785
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupQ34736939
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubesQ36522763
Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.Q36531631
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratoriesQ36541331
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasmaQ36542026
An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.Q36542226
Detection of human immunodeficiency virus type 1 (HIV-1) DNA and RNA sequences in HIV-1 antibody-positive blood donors in Uganda by the Roche AMPLICOR assay.Q36543907
Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paperQ36547353
Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiologyQ36829703
Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vaginaQ37882121
Maternal HIV-1 RNA serum levels at delivery and vertical transmission in Uganda.Q38888534
Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasmaQ40014818
HIV-1 burden as a marker of disease progression and clinical response to therapy in AIDS.Q40631528
Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study GroupQ44142380
Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and bloodQ45757928
Comparison of Serum and Plasma Viral RNA Measurements in Primary and Chronic Human Immunodeficiency Virus Type 1 InfectionQ45761943
Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with > or = 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious DQ45762216
Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1.Q45763443
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous ImmunoglobuliQ45763459
Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative cultureQ45767591
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA.Q45783125
Diurnal and short-term stability of HIV virus load as measured by gene amplificationQ45783301
Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levelsQ45786423
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectworkshopQ27556165
P304page(s)1471-1479
P577publication date1998-06-01
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleDeterminations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics
P478volume36